Investigation of Thiazolidine‐2,4‐Dione Derivatives as Acetylcholinesterase Inhibitors: Synthesis, In Vitro Biological Activities and In Silico Studies
ChemistryOpen · 2025
DOI: 10.1002/open.202400294 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistryOpen, 2025. Verfasst von Hanane Naeimi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Basic Sciences, University of Guilan, Rasht, 4193833697, Iran. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Acetylcholinesterase, Thiazolidinediones. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The inhibition of acetylcholinesterase (AChE), an enzyme responsible for the inactivation and decrease in acetylcholine in the cholinergic pathway, has been considered an attractive target for small‐molecule drug discovery in Alzheimer's disease (AD) therapy. In the present study, a series of TZD derivatives were designed, synthesized, and studied for drug likeness, blood–brain barrier (BBB) permeability, and adsorption, distribution, metabolism, excretion, and toxicity (ADMET). Additionally, docking studies of the designed compounds were performed on AChE. Additionally, all the TZD derivatives (CHT1‐5) showed an acceptable affinity for AChE inhibition, and the results showed convincing binding modes in the active site of AChE. Among them, 5‐(4‐methoxybenzylidene) thiazolidine‐2,4‐dione (CHT1) was identified as the most potent AChE inhibitor (IC 50 of 165.93 nM) with the highest antioxidant activity. Following the exposure of PC12 cells to Aβ1‐42 (100 μM), a marked reduction in cell survival was observed. Pretreatment of PC12 cells with TZD derivatives had a neuroprotective effect and significantly enhanced cell survival in response to Aβ‐induced toxicity. Western blotting analysis revealed that CHT1 (5 and 8 μM) downregulated p‐Tau and HSP70 expression levels. The results indicate that CHT1 is a promising and effective AchE‐I that could be utilized as a powerful candidate against AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Faculty of Basic Sciences, University of Guilan, Rasht, 4193833697, Iran.
- Department of Chemistry, Faculty of Sciences, University of Guilan, Rasht, 4193833697, Iran.
ORCID-Profile: Hanane Naeimi, Maryam Taheri, Hossein Ghafouri, Asadollah Mohammadi
Zitieren
APA
Naeimi, H., Taheri, M., Ghafouri, H., & Mohammadi, A. (2025). Investigation of Thiazolidine‐2,4‐Dione Derivatives as Acetylcholinesterase Inhibitors: Synthesis, In Vitro Biological Activities and In Silico Studies. ChemistryOpen. https://doi.org/10.1002/open.202400294
Vancouver
Naeimi H, Taheri M, Ghafouri H, Mohammadi A. Investigation of Thiazolidine‐2,4‐Dione Derivatives as Acetylcholinesterase Inhibitors: Synthesis, In Vitro Biological Activities and In Silico Studies. ChemistryOpen. 2025. doi:10.1002/open.202400294
BibTeX
@article{Naeimi2025,
author = {Naeimi, Hanane and Taheri, Maryam and Ghafouri, Hossein and Mohammadi, Asadollah},
title = {Investigation of Thiazolidine‐2,4‐Dione Derivatives as Acetylcholinesterase Inhibitors: Synthesis, In Vitro Biological Activities and In Silico Studies},
journal = {ChemistryOpen},
year = {2025},
doi = {10.1002/open.202400294}
}
EUVIMED